![](/img/cover-not-exists.png)
A randomized, first-in-human, healthy volunteer trial of BIVV009, a humanized antibody for the specific inhibition of the classical complement pathway
Bartko, Johann, Schoergenhofer, Christian, Schwameis, Michael, Firbas, Christa, Beliveau, Martin, Chang, Colin, Marier, Jean-Francois, Nix, Darrell, Gilbert, James C., Panicker, Sandip, Jilma, BerndLanguage:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt.1111
Date:
May, 2018
File:
PDF, 2.70 MB
english, 2018